Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis

Nicholas J Saba,1 Scott D Walter2 1Department of Ophthalmology, SUNY Downstate Medical Center, Brooklyn, NY, USA; 2Retina Consultants, PC, Hartford, CT, USACorrespondence: Scott D Walter, Retina Consultants, PC, 43 Woodland Street, Hartford, CT, USA, 06105, Tel +1860-206-2237, Fax +1860-409-7803, Em...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clinical Ophthalmology
المؤلفون الرئيسيون: Saba NJ, Walter SD
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Dove Medical Press 2023-09-01
الموضوعات:
beovu
brolucizumab
anti-vegf
intraocular inflammation
retinal vasculitis
الوصول للمادة أونلاين:https://www.dovepress.com/efficacy-safety-and-durability-of-brolucizumab-an-8-month-post-marketi-peer-reviewed-fulltext-article-OPTH

الانترنت

https://www.dovepress.com/efficacy-safety-and-durability-of-brolucizumab-an-8-month-post-marketi-peer-reviewed-fulltext-article-OPTH

مواد مشابهة